Tenax Therapeutics develops oral levosimendan, a drug candidate for pulmonary hypertension in heart failure with preserved ejection fraction. It last closed at $1.25 on Nov 20, down 10.07% on the day. The next earnings report for TENX is expected around Tue, Mar 9, 2027. For the quarter ended Sep 2026, TENX reported EPS of -$0.31 on revenue of $0. Over its last 8 reports the stock moved an average of 7.5% the session after earnings. Over the last 12 months TENX insiders bought $6.5M of stock on the open market and sold $0, according to SEC Form 4 filings.
AI Auto Pilots
Is TENX in one of our AI portfolios?
Five AI traders run real portfolios in the open, with every decision logged. Create a free account to see if they hold TENX.
Close to close, the session after each report, adjusted for splits. Past moves are no guide to the next one.
StreetAlpha callBullish64%
OPTIONS
+2
DARK POOL
+1
HISTORY
0
TECHNICAL
+1
StreetAlpha's call on TENXStart your 7 day free trial to see StreetAlpha's call before the report, with the options flow, dark pool, history and technical scores behind it.Sign up freeSign in
TENX · as of the Nov 20 close · updated each morning
Downtrend, oversold
The stock is 32% below its 20 day and 39% below its 50 day average. It is 630% below its 200 day average, so the longer trend is down. Momentum is weak (RSI 28), oversold. The nearest support is the 52 week low at $1.24, and the nearest resistance the Pivot at $1.28.
Short trendBearish
Long trendBearish
MomentumWeak
StretchOversold
VolatilityNormal, 10.9%/day
Key levels
$19.4052 week high+1452.0%
$9.12200 day average+629.6%
$5.31100 day average+324.8%
$1.84Swing high (Oct 22)+47.2%
$1.7450 day average+39.2%
$1.6520 day average+32.0%
$1.32Pivot R1+5.6%
$1.28Pivot+2.4%
$1.25Last close
$1.2452 week low−0.8%
$1.21Pivot S1−3.2%
Indicators
RSI (14)
28.38
Oversold below 30
Oversold
MACD
-0.14
Below its signal line
Bearish
Stochastic
8.5
Near the bottom of its range
Oversold
ADX (14)
24.5
Weak trend
Williams %R
-98.5
Oversold below −80, overbought above −20
Oversold
CCI (20)
-191.8
Oversold below −100, overbought above 100
Oversold
Rate of change
−26.0%
Change over 10 sessions
Bearish
ATR (14)
$0.14
Typical daily range, 10.9% of price
MA 10Below
MA 20Below
MA 50Below
MA 100Below
MA 200Below
Downtrend, oversold
Short trendBearish
Long trendBearish
MomentumWeak
StretchOversold
VolatilityNormal, 99.8%/day
Key levels
$19.4052 week high+1452.0%
$9.12200 day average+629.6%
$5.31100 day average+324.8%
$1.84Swing high (Oct 22)+47.2%
$1.7450 day average+39.2%
$1.6520 day average+32.0%
$1.32Pivot R1+5.6%
$1.28Pivot+2.4%
$1.25Last close
$1.2452 week low−0.8%
$1.21Pivot S1−3.2%
Indicators
RSI (14)
27.99
Oversold below 30
Oversold
MACD
-2.66
Below its signal line
Bearish
Stochastic
10.5
Near the bottom of its range
Oversold
ADX (14)
32.9
Trending down
Williams %R
-99.2
Oversold below −80, overbought above −20
Oversold
CCI (20)
-49.9
Oversold below −100, overbought above 100
Neutral
Rate of change
−32.8%
Change over 10 sessions
Bearish
ATR (14)
$1.25
Typical daily range, 99.8% of price
MA 10Below
MA 20Below
MA 50Below
MA 100Below
MA 200Below
What happened before, for TENX
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
What happened before
See how TENX did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record. Free with an account.
November seasonalityHow TENX usually does this month. See Seasonality
Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.
AI Day Trader
Watch Claude day trade the open, live.
Every session it trades SPY, QQQ, IWM and two daily stock picks, with each call logged before the move.
Whale options flow for TENXHow many large options trades hit TENX, the bullish and bearish split, and every trade with strike, premium and expiry are shown to AI Starter and AI Pro members.Sign up freeSign in
No whale options trades in TENX in the last 90 days.
From SEC Form 4 filings by TENX's officers, directors and 10% owners. Open market buys and sales only; option exercises, gifts, awards and tax withholding are left out. Not investment advice.
AI Auto Pilots
Paper trading
StreetAlpha runs autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether TENX is in one of them and how their past TENX trades turned out.
Tenax Therapeutics is a pharmaceutical company developing drugs for cardiopulmonary conditions. Its main candidate is oral levosimendan, a drug already marketed in other countries for acute heart failure, which it is testing for pulmonary hypertension in heart failure with preserved ejection fraction. No therapy is currently approved for that condition in the United States. The company is based in Chapel Hill, North Carolina, and targets patients with this form of pulmonary hypertension.